Altimmune, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jun 22, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| May 18, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 14, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Mar 16, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 6, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Nov 7, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $14 | 47% |
| Oct 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Oct 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 13, 2025 | UBS | maintain | Buy → Buy | $24 | 54% |
| Aug 13, 2025 | B. Riley Securities | maintain | Buy → Buy | $18 | 55% |
| Jul 10, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $15 | 53% |
| Jun 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Apr 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Apr 2, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $25 | 49% |
| Mar 14, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $25 | 49% |
| Mar 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Feb 28, 2025 | William Blair | initiate | — → Market Perform | $0 | 48% |
| Feb 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jan 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jan 8, 2025 | Stifel | initiate | — → Buy | $18 | 53% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Nov 12, 2024 | UBS | initiate | — → Buy | $26 | 54% |
| Aug 12, 2024 | B. Riley Securities | reiterate | Buy → Buy | $20 | 55% |
| Jun 25, 2024 | B. Riley Securities | reiterate | Buy → Buy | $20 | 55% |
| Jun 21, 2024 | Piper Sandler | maintain | Overweight → Overweight | $25 | 54% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| May 10, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $24 | 53% |
| Apr 29, 2024 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Apr 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Mar 28, 2024 | B. Riley Securities | reiterate | Buy → Buy | $20 | 55% |
| Feb 13, 2024 | B. Riley Securities | maintain | Buy → Buy | $20 | 55% |
| Dec 1, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Nov 9, 2023 | B. Riley Securities | maintain | Buy → Buy | $8 | 55% |
| Aug 14, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Aug 11, 2023 | B. Riley Securities | maintain | Buy → Buy | $15 | 55% |
| Jul 12, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $15 | 53% |
| May 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Mar 31, 2023 | JMP Securities | reiterate | — → Market Outperform | $15 | 53% |
| Mar 22, 2023 | JMP Securities | reiterate | — → Market Outperform | $26 | 53% |
| Mar 22, 2023 | Goldman Sachs | downgrade | Buy → Neutral | $6 | 54% |
| Mar 9, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $50 | 44% |
| Feb 6, 2023 | JMP Securities | reiterate | — → Market Outperform | $26 | 53% |
| Jan 20, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $50 | 44% |
| Jan 18, 2023 | Evercore ISI Group | maintain | — → Outperform | $25 | 58% |
| Dec 1, 2022 | Goldman Sachs | initiate | — → Buy | $20 | 54% |
| Nov 11, 2022 | JMP Securities | maintain | — → Market Outperform | $26 | 53% |
| Sep 16, 2022 | Guggenheim | maintain | — → Buy | $26 | 52% |
No cross-platform signals in the last 90 days